Lenz & Staehelin with SQ Innovation on funding round
Lenz & Staehelin advised SQ Innovation, a life-science company specialised in the treatment of worsening heart failure, throughout closing of its Series B financing round.
Newly-appointed member of the company’s supervisory board Marco van der Poel led the operation, with further support of new and existing shareholders.
The Lenz & Staehelin team
The Lenz & Staehelin team working on the matter included Simone Ehrsam (pictured right), Tino Gaberthüel (pictured left), Nicolas Lehmann, Raphael Fries and Lucas Gericke (all corporate and M&A), as well as Peter Ling (IP).
